Determination of Pazufloxacin Mesylate in Human Plasma and Urine by RP-HPLC

李芹,王睿,裴斐,柴栋,方翼
DOI: https://doi.org/10.3969/j.issn.1001-6821.2004.05.016
2004-01-01
Abstract:Objective To establish an analytical method for the determination ofpazufloxacin mesylate in human plasma and urine. Methods Pazufloxacin mesylateand internal standard o-phthalic acid were precipitated from plasma with hydrochloricacid, while urine sample was injected after diluted and centrifuged. A reversed phaseHPLC method was carried out. Results The calibration curve was linear in humanplasma within the range of 0.15~10.0 mg.mL-1(γ=0.9998). The absolute recoveriesof pazufloxacin mesylate at the concentrations of 0.25, 2.0, 8.0 mg.mL-1 were allhigher than 78%, and the relative recoveries were from 100% to 104%. The RSD ofthe within-day and between-day variations were lower than 17% and 13%,respectively. The calibration curve was linear in human urine within the range of2.5~50.0 mg.mL-1 (γ=0.9993). The absolute recoveries of pazufloxacin mesylateat the concentrations of 5,20,40 mg.mL-1 were all higher than 89%, and therelative recoveries were from 93% to 101%. The RSD of the within-day and between-day variations were lower than 8% and 7%, respectively. Conclusion This RP-HPLCmethod is simple, sensitive and accurate. It is suitable for routine determination ofpazufloxacin mesylate levels in human plasma and urine and for its pharmacokineticstudy.
What problem does this paper attempt to address?